Propafenone-Induced QRS Widening in a Child With Arrhythmogenic Right Ventricular Cardiomyopathy: A Case Report and Literatures Review

Frontiers in Pediatrics
Yan-Qiu ChuHong Wang

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare cardiac disease in children, and can lead to sudden cardiac death (SCD). Propafenone is classIC antiarrhythmic medication, and its side effects include cardiovascular compromise in the form of hypotension, bradycardia, ventricular dysrhythmias, QRS widening, and heart block. Propafenone has been reported causing QRS widening, but rarely in children. In this article, we presented a boy diagnosed with ARVC who meets diagnosis criteria based on typical symptoms, electrocardiograph (ECG), echocardiography (Echo), cardiac magnetic resonance imaging (CMRI), sudden death of first family member, and genetic mutation in desmosomal DSG2 gene. Antiarrhythmic drugs have been used for treating patients with ARVC, by eliminating or decreasing the occurring frequency of arrhythmias. As his ECG showed frequent premature ventricular contractions (PVC), he was prescribed with oral propafenone. One day after the drug treatment, he presented dizziness accompanied with significant QRS widening in ECG. His dizziness was improved when Propafenone dose was reduced, and resolved after sotalol replacement, with ECG recovered to nearly normal state of QRS. Propafenone may lead to QRS wideni...Continue Reading

References

Aug 24, 1999·International Journal of Cardiology·W ShamimA J Coats
Oct 3, 1999·Zeitschrift für Kardiologie·M W Norman, W J McKenna
Mar 10, 2000·Pacing and Clinical Electrophysiology : PACE·R MantovanD C Shah
Dec 29, 2000·Journal of the American College of Cardiology·A NavaG Thiene
Dec 12, 2001·Journal of the American College of Cardiology·C GemayelP D Thompson
Dec 14, 2005·Circulation·Darshan DalalHugh Calkins
Jan 31, 2006·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Philippine KièsErnst E van der Wall
Apr 14, 2009·Lancet·Cristina BassoGaetano Thiene
Aug 8, 2009·Journal of the American College of Cardiology·Gregory M MarcusUNKNOWN Multidisciplinary Study of Right Ventricular Dysplasia Investigators
Jun 16, 2010·The Canadian Journal of Cardiology·Adam YeungKenneth Gin
Jan 14, 2012·Journal of the American College of Cardiology·Ryan J TedfordStuart D Russell
Jun 4, 2013·Current Treatment Options in Cardiovascular Medicine·Cynthia A James, Hugh Calkins
Jul 19, 2014·Journal of the American College of Cardiology·Anneline S J M te RieleHarikrishna Tandri
Sep 1, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Silvia G PrioriUNKNOWN Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Eur
Dec 12, 2017·Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır·Zübeyde BayramNihal Özdemir
Jan 19, 2018·Acta Cardiologica·János Tomcsányi, Kristóf Tomcsányi
Jun 20, 2018·Journal of Community Hospital Internal Medicine Perspectives·Amr IdrisKi Park
Nov 21, 2018·International Journal of Cardiology·Liang ChenJiangping Song

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2021 Meta ULC. All rights reserved